| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| Gesamt | 44.704.197 $ | 95,84 | 983.041 | ||||||
| GILEAD SCIENCES INC | GILEAD SCIENCES | EC | 375558103 | Long | Börsenkurs (Stufe 1) | 2.580.621 $ | 5,53 | 20.426 | |
| VERTEX PHARMACEUTICALS INC | VERTEX PHARM | EC | 92532F100 | Long | Börsenkurs (Stufe 1) | 2.484.643 $ | 5,33 | 5.002 | |
| ASTRAZENECA PLC | ASTRAZENECA PLC | EC | G0593M107 | Long | Börsenkurs (Stufe 1) | 2.160.530 $ | 4,63 | 11.394 | |
| ROIVANT SCIENCES LTD | ROIVANT SCIENCES | EC | G76279101 | Long | Börsenkurs (Stufe 1) | 1.711.283 $ | 3,67 | 48.355 | |
| ARGENX SE | ARGENX SE - ADR | EC | 04016X101 | Long | Börsenkurs (Stufe 1) | 1.675.553 $ | 3,59 | 1.806 | |
| NEUROCRINE BIOSCIENCES INC | NEUROCRINE BIOSC | EC | 64125C109 | Long | Börsenkurs (Stufe 1) | 1.639.340 $ | 3,51 | 9.727 | |
| INCYTE CORP | INCYTE CORP | EC | 45337C102 | Long | Börsenkurs (Stufe 1) | 1.638.165 $ | 3,51 | 14.451 | |
| AXSOME THERAPEUTICS INC | AXSOME THERAPEUT | EC | 05464T104 | Long | Börsenkurs (Stufe 1) | 1.598.593 $ | 3,43 | 6.531 | |
| APOGEE THERAPEUTICS INC | APOGEE THERAPEUT | EC | 03770N101 | Long | Börsenkurs (Stufe 1) | 1.530.775 $ | 3,28 | 11.533 | |
| IONIS PHARMACEUTICALS INC | IONIS PHARMACEUT | EC | 462222100 | Long | Börsenkurs (Stufe 1) | 1.223.445 $ | 2,62 | 15.430 | |
| ASCENDIS PHARMA A/S | ASCENDIS PHARMA | EC | K08588103 | Long | Börsenkurs (Stufe 1) | 1.222.911 $ | 2,62 | 4.585 | |
| INSMED INC | INSMED INC | EC | 457669307 | Long | Börsenkurs (Stufe 1) | 1.214.828 $ | 2,60 | 11.394 | |
| PROTAGONIST THERAPEUTICS INC | PROTAGONIST THER | EC | 74366E102 | Long | Börsenkurs (Stufe 1) | 1.124.181 $ | 2,41 | 9.171 | |
| PERSONALIS INC | PERSONALIS INC | EC | 71535D106 | Long | Börsenkurs (Stufe 1) | 1.057.582 $ | 2,27 | 78.924 | |
| RHYTHM PHARMACEUTICALS INC | RHYTHM PHARMACEU | EC | 76243J105 | Long | Börsenkurs (Stufe 1) | 1.049.122 $ | 2,25 | 9.449 | |
| ABBVIE INC | ABBVIE INC | EC | 00287Y109 | Long | Börsenkurs (Stufe 1) | 909.175 $ | 1,95 | 3.613 | |
| JAZZ PHARMACEUTICALS PLC | JAZZ PHARMACEUTI | EC | G50871105 | Long | Börsenkurs (Stufe 1) | 870.625 $ | 1,87 | 3.613 | |
| AMGEN INC | AMGEN INC | EC | 031162100 | Long | Börsenkurs (Stufe 1) | 855.327 $ | 1,83 | 2.362 | |
| BIOGEN INC | BIOGEN INC | EC | 09062X103 | Long | Börsenkurs (Stufe 1) | 840.689 $ | 1,80 | 3.891 | |
| CATALYST PHARMACEUTICALS INC | CATALYST PHARMAC | EC | 14888U101 | Long | Börsenkurs (Stufe 1) | 742.439 $ | 1,59 | 23.622 | |
| HALOZYME THERAPEUTICS INC | HALOZYME THERAPE | EC | 40637H109 | Long | Börsenkurs (Stufe 1) | 737.773 $ | 1,58 | 9.426 | |
| MEIRAGTX HOLDINGS PLC | MEIRAGTX HOLDING | EC | G59665102 | Long | Börsenkurs (Stufe 1) | 735.876 $ | 1,58 | 54.469 | |
| KRYSTAL BIOTECH INC | KRYSTAL BIOTECH | EC | 501147102 | Long | Börsenkurs (Stufe 1) | 722.898 $ | 1,55 | 1.945 | |
| NUVALENT INC | NUVALENT INC-A | EC | 670703107 | Long | Börsenkurs (Stufe 1) | 686.413 $ | 1,47 | 5.558 | |
| ABIVAX SA | ABIVAX SA-ADR | EC | 00370M103 | Long | Börsenkurs (Stufe 1) | 685.090 $ | 1,47 | 5.141 | |
| EDGEWISE THERAPEUTICS INC | EDGEWISE THERAPE | EC | 28036F105 | Long | Börsenkurs (Stufe 1) | 643.579 $ | 1,38 | 15.840 | |
| NURIX THERAPEUTICS INC | NURIX THERAPEUTI | EC | 67080M103 | Long | Börsenkurs (Stufe 1) | 627.000 $ | 1,34 | 25.845 | |
| SANOFI SA | SANOFI-ADR | EC | 80105N105 | Long | Börsenkurs (Stufe 1) | 622.409 $ | 1,33 | 14.590 | |
| ORUKA THERAPEUTICS INC | ORUKA THERAPEUTI | EC | 687604108 | Long | Börsenkurs (Stufe 1) | 621.555 $ | 1,33 | 6.531 | |
| KYMERA THERAPEUTICS INC | KYMERA THERAPEUT | EC | 501575104 | Long | Börsenkurs (Stufe 1) | 617.498 $ | 1,32 | 5.385 | |
| SPYRE THERAPEUTICS INC | SPYRE THERAPEUTI | EC | 00773J202 | Long | Börsenkurs (Stufe 1) | 592.163 $ | 1,27 | 6.670 | |
| BIONTECH SE | BIONTECH SE-ADR | EC | 09075V102 | Long | Börsenkurs (Stufe 1) | 583.051 $ | 1,25 | 6.266 | |
| AGIOS PHARMACEUTICALS INC | AGIOS PHARMACEUT | EC | 00847X104 | Long | Börsenkurs (Stufe 1) | 525.960 $ | 1,13 | 14.173 | |
| NEWAMSTERDAM PHARMA COMPANY NV | NEWAMSTERDAM PHA | EC | N62509109 | Long | Börsenkurs (Stufe 1) | 503.877 $ | 1,08 | 14.868 | |
| CYTOKINETICS INC | CYTOKINETICS INC | EC | 23282W605 | Long | Börsenkurs (Stufe 1) | 485.327 $ | 1,04 | 5.697 | |
| CELLDEX THERAPEUTICS INC | CELLDEX THERAPEU | EC | 15117B202 | Long | Börsenkurs (Stufe 1) | 475.693 $ | 1,02 | 12.784 | |
| TREVI THERAPEUTICS INC | TREVI THERAPEUTI | EC | 89532M101 | Long | Börsenkurs (Stufe 1) | 453.512 $ | 0,97 | 24.317 | |
| ALNYLAM PHARMACEUTICALS INC | ALNYLAM PHARMACE | EC | 02043Q107 | Long | Börsenkurs (Stufe 1) | 418.432 $ | 0,90 | 1.390 | |
| VERACYTE INC | VERACYTE INC | EC | 92337F107 | Long | Börsenkurs (Stufe 1) | 408.056 $ | 0,87 | 6.948 | |
| CANDEL THERAPEUTICS INC | CANDEL THERAPEUT | EC | 137404109 | Long | Börsenkurs (Stufe 1) | 377.835 $ | 0,81 | 36.683 | |
| NATERA INC | NATERA INC | EC | 632307104 | Long | Börsenkurs (Stufe 1) | 377.316 $ | 0,81 | 1.390 | |
| REZOLUTE INC | REZOLUTE INC | EC | 76200L309 | Long | Börsenkurs (Stufe 1) | 375.726 $ | 0,81 | 72.255 | |
| CULLINAN THERAPEUTICS INC | CULLINAN THERAPE | EC | 230031106 | Long | Börsenkurs (Stufe 1) | 371.957 $ | 0,80 | 20.426 | |
| CRINETICS PHARMACEUTICALS INC | CRINETICS PHARMA | EC | 22663K107 | Long | Börsenkurs (Stufe 1) | 369.186 $ | 0,79 | 9.866 | |
| XERIS BIOPHARMA HOLDINGS INC | XERIS BIOPHARMA | EC | 98422E103 | Long | Börsenkurs (Stufe 1) | 368.668 $ | 0,79 | 46.549 | |
| DESIGN THERAPEUTICS INC | DESIGN THERAPEUT | EC | 25056L103 | Long | Börsenkurs (Stufe 1) | 311.640 $ | 0,67 | 21.537 | |
| MONTE ROSA THERAPEUTICS INC | MONTE ROSA THERA | EC | 61225M102 | Long | Börsenkurs (Stufe 1) | 306.009 $ | 0,66 | 12.645 | |
| DISC MEDICINE INC | DISC MEDICINE IN | EC | 254604101 | Long | Börsenkurs (Stufe 1) | 294.754 $ | 0,63 | 4.030 | |
| RAPPORT THERAPEUTICS INC | RAPPORT THERAPEU | EC | 75383L102 | Long | Börsenkurs (Stufe 1) | 272.147 $ | 0,58 | 6.531 | |
| ARVINAS INC | ARVINAS INC | EC | 04335A105 | Long | Börsenkurs (Stufe 1) | 254.469 $ | 0,55 | 30.622 | |
| ICON PLC | ICON PLC | EC | G4705A100 | Long | Börsenkurs (Stufe 1) | 241.457 $ | 0,52 | 1.390 | |
| TECTONIC THERAPEUTIC INC | TECTONIC THERAPE | EC | 878972108 | Long | Börsenkurs (Stufe 1) | 238.838 $ | 0,51 | 6.948 | |
| SIONNA THERAPEUTICS INC | SIONNA THERAPEUT | EC | 829401108 | Long | Börsenkurs (Stufe 1) | 213.923 $ | 0,46 | 4.863 | |
| WAVE LIFE SCIENCES LTD | WAVE LIFE SCIENC | EC | Y95308105 | Long | Börsenkurs (Stufe 1) | 207.243 $ | 0,44 | 35.670 | |
| INTELLIA THERAPEUTICS INC | INTELLIA THERAPE | EC | 45826J105 | Long | Börsenkurs (Stufe 1) | 197.490 $ | 0,42 | 11.672 | |
| ATRIUM THERAPEUTICS INC | ATRIUM THERAPEUT | EC | 04965N104 | Long | Börsenkurs (Stufe 1) | 181.279 $ | 0,39 | 13.478 | |
| IQVIA HOLDINGS INC | IQVIA HOLDINGS I | EC | 46266C105 | Long | Börsenkurs (Stufe 1) | 161.145 $ | 0,35 | 834 | |
| ANNEXON INC | ANNEXON INC | EC | 03589W102 | Long | Börsenkurs (Stufe 1) | 142.019 $ | 0,30 | 24.872 | |
| ADMA BIOLOGICS INC | ADMA BIOLOGICS I | EC | 000899104 | Long | Börsenkurs (Stufe 1) | 84.897 $ | 0,18 | 10.143 | |
| ALDEYRA THERAPEUTICS INC | ALDEYRA THERAPEU | EC | 01438T106 | Long | Börsenkurs (Stufe 1) | 80.207 $ | 0,17 | 37.656 | |
| Alkermes PLC | ALKERMES PLC CVR | EC | Long | Modellwert (Stufe 2) | beschränkt | 0 $ | 0,00 | 39.859 | |
| Gesamt | 44.704.197 $ | 95,84 | 983.041 |